Cleared Traditional

EP Granules™ BVF (K180853) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180853 · Elute, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
126d
Days
Class 2
Risk

K180853 is an FDA 510(k) clearance for the EP Granules™ BVF. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Elute, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on August 6, 2018 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Elute, Inc. devices

Submission Details

510(k) Number K180853 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2018
Decision Date August 06, 2018
Days to Decision 126 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 122d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 201
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K180853.
ALTAPORE
K181225 · Baxter Healthcare Corporation · Aug 2018
CarriGen PF
K182107 · Etex Corporation · Aug 2018
Actifuse Flow
K181306 · Baxter Healthcare Corporation · Aug 2018
JGH1 Core Deccompression Procedure Kit
K181585 · AgNovos Healthcare USA, LLC · Jul 2018
JGH1 Bone Graft Substitute
K181342 · AgNovos Healthcare USA, LLC · Jul 2018
DSM Biomedical Calcium Phosphate Cement with Microspheres
K173572 · Kensey Nash Corporation Dba Dsm Biomedical · May 2018